|
Dr. Perlmutter is Executive Vice President for Research and Development at Amgen. A graduate of Reed College (Portland Oregon) Dr. Perlmutter received his M.D. and Ph.D. degrees from Washington University (St. Louis) in 1979. Thereafter he pursued clinical training in internal medicine at the Massachusetts General Hospital and at the University of California at San Francisco. From 1981 to 1984 he was a Lecturer in the Division of Biology at the California Institute of Technology. He joined the Departments of Medicine and Biochemistry and the Howard Hughes Medical Institute at the University of Washington (Seattle) in 1984 and in 1989 became Professor and founding Chairman of the Department of Immunology there. During this period Dr. Perlmutter focused his scientific efforts on the elucidation of signaling pathways governing lymphocyte development and activation. In 1997 he left the University of Washington to join Merck and Co. ultimately rising to the rank of Executive Vice President Worldwide Basic and Preclinical Research. He left Merck in 2001 to join Amgen in California. Dr. Perlmutter is also a director of Stem Cells Inc. a Trustee of Reed College and Chairman of the Board of Directors of the Institute for Systems Biology a not-for-profit research institute based in Seattle Washington. He was previously President of the American Association of Immunologists and is a Fellow of the American Academy of Arts and Sciences. | 